|1.||Rae, Giles A: 1 article (06/2013)|
|2.||Tronco Júnior, Marcos F: 1 article (06/2013)|
|3.||Martini, Alessandra C: 1 article (06/2013)|
|4.||Zampronio, Aleksander R: 1 article (06/2013)|
|5.||Chichorro, Juliana G: 1 article (06/2013)|
|6.||Teodoro, Fernanda C: 1 article (06/2013)|
|7.||Cabrini, D A: 1 article (04/2011)|
|8.||Brito, H O: 1 article (04/2011)|
|9.||Zampronio, A R: 1 article (04/2011)|
|10.||Reis, R C: 1 article (04/2011)|
|1.||Neuralgia (Stump Neuralgia)
06/01/2013 - "Moreover, heat, but not cold or mechanical, hyperalgesia induced by constriction of the infraorbital nerve, a model of trigeminal neuropathic pain, was abolished by pretreatment with SR140333B. "
06/01/2013 - "Systemic treatment with SR140333B (3 mg/kg) also reduced carrageenan-induced heat hyperalgesia, but did not exert any influence on carrageenan-induced cold hyperalgesia. "
06/01/2013 - "However, substance P at this latter dose induced orofacial heat hyperalgesia, which was reduced by the pre-treatment of rats with a non-peptide NK1 receptor antagonist (SR140333B, 3mg/kg). "
04/12/2011 - "On the other hand, intracerebroventricular administration of SR140333B significantly reduced the fever induced by peripheral injection of LPS. "
04/12/2011 - "Our results show that the systemic injection of SR140333B did not modify the fever induced by LPS at a dose that is able to reduce protein extravasation induced by SP in the skin. "
04/12/2011 - "Considering that the febrile response can result from the generation of several endogenous pyrogens, among them interleukin (IL)-1β and macrophage inflammatory protein-1α (CCL3/MIP-1α), we also examined the effect of SR140333B on the fever induced by these cytokines which act through prostaglandin-dependent and -independent mechanisms, respectively. "